iiinova — where your digital self keeps evolving

Scott Dietrich @pcc-pharmd.bsky.social · 07/08/2025

New ED pharmD study on lytics for PE-arrest with both tPA and TNK pt's ROSC seen in 9/21 with tPA vs only 2/11 with TNK. Not a huge study, but super interesting to see if another study comes out with similar tPA > TNK results bit.ly/4mbUqYG

131

Scott Dietrich @pcc-pharmd.bsky.social · 24/05/2025

New SRMA in-press with 6 studies comparing re-arrest rates post-ROSC btwn epi and norepi gtts with NE showing lower re-arrest rates and a non-significant increase is survival to discharge Should likely be doing NE gtts in most everyone post-ROSC at this point

140

Scott Dietrich @pcc-pharmd.bsky.social · 24/04/2025

We're trying steroids and vasopressin again in IHCA Small pilot study showing benefit, remains to be seen on a larger scale if the results hold up or not, but 38% vs 16% ROSC looks good www.sciencedirect.com/science/arti...

041

Reposted by Scott Dietrich

Caitlin Brown @cbthepharmd.bsky.social · 19/04/2025

⁉️Which patients require reversal in warfarin associated GIB? We lack large RCTs to guide treatment. Check out our retrospective study evaluating treatments in GIB www.sciencedirect.com/science/arti...

sciencedirect.com

Comparison of anticoagulation reversal strategies for warfarin associated acute gastrointestinal bleeding

Gastrointestinal bleeding (GIB) is a common complication associated with warfarin use. However, the optimal approach for anticoagulation reversal—whet…

284

Scott Dietrich @pcc-pharmd.bsky.social · 25/12/2024

New (open access) study testing non-specific reversal agents against milvexian (a factor XI inhibitor). Looks like aPCC would be the early front runner in terms of effectiveness in vitro bit.ly/41NO0Im

240

Scott Dietrich @pcc-pharmd.bsky.social · 18/12/2024

New pediatric study in press by Colorado PharmDs showing no diff in pain relief for ketorolac doses >15 mg (avg 0.44 mg/kg) vs capped doses of 15 mg (avg 0.26 mg/kg) aligning with adult literature

110

Scott Dietrich @pcc-pharmd.bsky.social · 07/12/2024

I think we all already knew this, but new study showing benzo + olanzapine just as safe as olanzapine monotherapy in acutely agitated ED patients with low rates of cardiorespiratory depression bit.ly/3Zqdf0D

160

Reposted by Scott Dietrich

EMPoweRx 2025 Conference @emprx25.bsky.social · 22/11/2024

👋 Hello new (and old) friends! Can’t wait to connect with you all here as our EM Pharmacotherapy community grows! In the mean time follow the link in our Bio to learn more about #EMPRx25 - Registration is OPEN (🎲Vegas anyone 👀) #PharmSky #SkyRx #EMSky

0206

Reposted by Scott Dietrich

Thom Mack @thommytox.bsky.social · 23/11/2024

Looks like I’ve made a lot of new friends here across med/pharm/bio/eco! I’m Thom Mack, a Clinical Toxicologist☠️ & EM PharmD in the SW🏜️. During ☠️-fellowship I was fascinated by rattle-🐍s & stayed for a 2nd fellowship in 🐍 envenoming. So let’s talk about SNAKES! #MedSky #ToxSky #RxSky

media.tenor.com

a store front with a sign that says pet shop

ALT: a store front with a sign that says pet shop

7406

Scott Dietrich @pcc-pharmd.bsky.social · 20/11/2024

This just came up on that other place with more/new data from Annexa-I that does not look good…. x.com/gilbertpharm...

x.com

150

Scott Dietrich @pcc-pharmd.bsky.social · 16/11/2024

For those of you in copperhead country, are you doing maintenance dosing for Crofab after control?

210